INS and sarcopenia: Thus, we hypothesize that L-2-amino-3-oxobutanoic acid may be involved in the pathogenesis of sarcopenia through the modulation of glycine metabolism, potentially affecting insulin sensitivity, antioxidative, and anti-inflammatory capacities.